Regulation by Lactoferrin of Epidermal Langerhans Cell Migration

  • Ian Kimber
  • Marie Cumberbatch
  • Rebecca J. Dearman
  • Pauline Ward
  • Denis R. Headon
  • Orla M. Conneely
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 443)


Lactoferrin is an iron-binding glycoprotein that shares structural homology with transferrin and which is found in milk, other epithelial secretions and the secondary granules of neutrophils1. One function ascribed to lactoferrin is that of antibacterial activity which is effected primarily through the sequestration of iron necessary for microbial growth1,2. It is recognized, however, that in addition to its bacteriostatic properties, lactoferrin may serve as a modulator of immune and inflammatory responses. Of particular interest is the observation that this glycoprotein may influence the production of some cytokines, including proinflammatory cytokines 1–3. Among the cytokines shown to be regulated negatively by lactoferrin are tumour necrosis factor a (TNF-α), interleukin 1β (IL-1β) and granulocyte/macrophage colony-stimulating factor (GM-CSF)2–4. It has been demonstrated that (bovine) lactoferrin administered intravenously to mice prior to an injection of bacterial lipopolysaccharide (LPS) inhibited significantly the production of TNF-α normally induced by LPS5. It has been argued, however, that the ability of lactoferrin to inhibit the stimulation of TNF-α by LPS may be secondary to its capacity to bind LPS and thereby compromise the signal for cytokine production3.


Drain Lymph Node Intradermal Injection Skin Sensitization Human Lactoferrin Bovine Serum Albu 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lonnerdal, B, Lyer S. (1995) Lactoferrin: molecular structure and biological function. Ann. Rev. Nutr. 15: 93–110.CrossRefGoogle Scholar
  2. 2.
    Sanchez, L, Calvo, M, Brock, JH. (1992) Biological role of lactoferrin. Arch. Dis. Childhood 67: 697–661.CrossRefGoogle Scholar
  3. 3.
    Brock, J. (1995) Lactoferrin: a multifunctional immunoregulatory protein? Immunol. Today 16: 417–419.Google Scholar
  4. 4.
    Penco, S, Pastorino, S, Bianchi-Scarra, G, Garre C. (1995) Lactoferrin down-modulates the activity of the granulocyte macrophage colony-stimulating factor promoter in interleukin-1(3-stimulated cells. J. Biol. Chem. 270: 12263–12268.PubMedCrossRefGoogle Scholar
  5. 5.
    Machnicki, M, Zimecki, M, Zagulski, T. (1993) Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Path. 74: 433–439.Google Scholar
  6. 6.
    Kimber, I, Cumberbatch, M. (1992) Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol. Appl. Pharmacol. 117: 137–146.PubMedCrossRefGoogle Scholar
  7. 7.
    Kinnaird, A, Peters, SW, Foster, JR, Kimber, I. (1989) Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice. Int. Arch. Allergy Appl. Immunol. 89: 202–210.PubMedCrossRefGoogle Scholar
  8. 8.
    Cumberbatch, M, Kimber, I. (1990) Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunology 71: 404–410.PubMedGoogle Scholar
  9. 9.
    Enk, AH, Katz, SI. (1992) Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci USA 89: 1398–1402.PubMedCrossRefGoogle Scholar
  10. 10.
    Cumberbatch, M, Kimber, 1. (1992) Dermal tumour necrosis factor-a induces dendritic cell migration to draining lymph nodes and possibly provides one stimulus for Langerhans cell migration. Immunology 75: 257 263.Google Scholar
  11. 11.
    Cumberbatch, M, Fielding, I, Kimber, I. (1994) Modulation of epidermal Langerhans cell frequency by tumour necrosis factor-a. Immunology 81: 395–401.PubMedGoogle Scholar
  12. 12.
    Cumberbatch, M, Kimber, I. (1995) Tumour necrosis factor-a is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84: 31–35.PubMedGoogle Scholar
  13. 13.
    Ward, PP, Piddington, CS, Cunningham, GA, Zhou, X, Wyatt, RD, Conneely, OM. (1995) A system for production of commercial quantities of human lactoferrin: a broad spectrum antibiotic. Bio/Technology 13: 498–502.PubMedCrossRefGoogle Scholar
  14. 14.
    Ho. J, Furmanski, P. (1995) Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373: 721–724.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Ian Kimber
    • 1
  • Marie Cumberbatch
    • 1
  • Rebecca J. Dearman
    • 1
  • Pauline Ward
    • 2
  • Denis R. Headon
    • 3
  • Orla M. Conneely
    • 2
  1. 1.Zeneca Central Toxicology LaboratoryMacclesfieldUK
  2. 2.Department of Cell BiologyBaylor College of MedicineHoustonUSA
  3. 3.Agennix IncorporatedHoustonUSA

Personalised recommendations